Short Interest in Sonova Holding (OTCMKTS:SONVY) Declines By 77.6%

Sonova Holding (OTCMKTS:SONVY) saw a large decrease in short interest in January. As of January 30th, there was short interest totaling 8,247 shares, a decrease of 77.6% from the January 15th total of 36,769 shares. Based on an average daily volume of 47,269 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 47,269 shares, the short-interest ratio is presently 0.2 days.

Sonova Price Performance

Shares of SONVY stock traded down $0.09 during trading hours on Tuesday, hitting $53.40. 21,076 shares of the company were exchanged, compared to its average volume of 23,045. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The firm has a fifty day simple moving average of $52.89 and a 200 day simple moving average of $54.48. Sonova has a 52-week low of $47.55 and a 52-week high of $68.76.

Analyst Ratings Changes

A number of research analysts recently commented on SONVY shares. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Zacks Research cut shares of Sonova from a “hold” rating to a “strong sell” rating in a report on Tuesday, December 9th. Finally, BNP Paribas Exane began coverage on shares of Sonova in a research report on Monday, October 20th. They set an “underperform” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, three have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold”.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.